GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Kimia Farma Tbk (ISX:KAEF) » Definitions » E10

PT Kimia Farma Tbk (ISX:KAEF) E10 : Rp-3.12 (As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is PT Kimia Farma Tbk E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

PT Kimia Farma Tbk's adjusted earnings per share data for the three months ended in Sep. 2024 was Rp-58.260. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is Rp-3.12 for the trailing ten years ended in Sep. 2024.

During the past 12 months, PT Kimia Farma Tbk's average E10 Growth Rate was -108.50% per year. During the past 3 years, the average E10 Growth Rate was -39.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of PT Kimia Farma Tbk was -39.70% per year. The lowest was -39.70% per year. And the median was -39.70% per year.

As of today (2025-03-23), PT Kimia Farma Tbk's current stock price is Rp386.00. PT Kimia Farma Tbk's E10 for the quarter that ended in Sep. 2024 was Rp-3.12. PT Kimia Farma Tbk's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of PT Kimia Farma Tbk was 179.52. The lowest was 17.05. And the median was 45.38.


PT Kimia Farma Tbk E10 Historical Data

The historical data trend for PT Kimia Farma Tbk's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kimia Farma Tbk E10 Chart

PT Kimia Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 47.05 48.70 42.30 10.30

PT Kimia Farma Tbk Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.65 10.30 7.95 4.54 -3.12

Competitive Comparison of PT Kimia Farma Tbk's E10

For the Medical Distribution subindustry, PT Kimia Farma Tbk's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kimia Farma Tbk's Shiller PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Tbk's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PT Kimia Farma Tbk's Shiller PE Ratio falls into.



PT Kimia Farma Tbk E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PT Kimia Farma Tbk's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-58.26/130.3609*130.3609
=-58.260

Current CPI (Sep. 2024) = 130.3609.

PT Kimia Farma Tbk Quarterly Data

per share eps CPI Adj_EPS
201412 20.180 98.819 26.621
201503 7.910 98.388 10.481
201506 6.030 99.766 7.879
201509 15.509 101.037 20.010
201512 17.617 102.133 22.486
201603 7.560 102.764 9.590
201606 9.290 103.212 11.734
201609 14.446 104.142 18.083
201612 16.850 105.222 20.876
201703 5.260 106.476 6.440
201706 11.860 107.722 14.353
201709 17.440 108.020 21.047
201712 24.274 109.017 29.027
201803 6.700 110.097 7.933
201806 20.650 111.085 24.233
201809 13.240 111.135 15.531
201812 47.914 112.430 55.556
201903 3.710 112.829 4.286
201906 4.883 114.730 5.548
201909 -1.070 114.905 -1.214
201912 -9.823 115.486 -11.088
202003 4.711 116.252 5.283
202006 4.035 116.630 4.510
202009 -2.050 116.397 -2.296
202012 -3.522 117.318 -3.914
202103 3.114 117.840 3.445
202106 7.256 118.184 8.004
202109 42.690 118.262 47.058
202112 0.061 119.516 0.067
202203 1.040 120.948 1.121
202206 -37.971 123.322 -40.138
202209 4.350 125.298 4.526
202212 -1.717 126.098 -1.775
202303 0.070 126.953 0.072
202306 -3.981 127.663 -4.065
202309 -27.975 128.151 -28.457
202312 -243.320 129.395 -245.137
202403 -18.470 130.607 -18.435
202406 -22.300 130.792 -22.227
202409 -58.260 130.361 -58.260

Add all the adjusted EPS together and divide 10 will get our e10.


PT Kimia Farma Tbk  (ISX:KAEF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of PT Kimia Farma Tbk was 179.52. The lowest was 17.05. And the median was 45.38.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


PT Kimia Farma Tbk E10 Related Terms

Thank you for viewing the detailed overview of PT Kimia Farma Tbk's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kimia Farma Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.

PT Kimia Farma Tbk Headlines

No Headlines